Additionally, the 36-month beta value for PBM is -0.53.
The public float for PBM is 46.96M and currently, short sellers hold a 1.43% ratio of that float. The average trading volume of PBM on November 22, 2024 was 7.21M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
PBM) stock’s latest price update
Psyence Biomedical Ltd (NASDAQ: PBM)’s stock price has increased by 2.13 compared to its previous closing price of 0.05. However, the company has seen a -5.14% decrease in its stock price over the last five trading sessions. globenewswire.com reported 2024-11-19 that NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced an effective date for its previously-announced share consolidation. At its Annual General and Special Meeting of Shareholders, which was held on November 12, 2024, Psyence Biomed’s shareholders approved a consolidation of the Company’s common shares at a ratio of up to 1 common share for every 75 common shares held, with the final ratio to be determined by the Company’s board of directors (the “Board”). Also, as previously announced, the Board approved a 1-for-75 consolidation of its outstanding common shares.
PBM’s Market Performance
Psyence Biomedical Ltd (PBM) has experienced a -5.14% fall in stock performance for the past week, with a -48.94% drop in the past month, and a -89.36% drop in the past quarter. The volatility ratio for the week is 14.14%, and the volatility levels for the past 30 days are at 16.52% for PBM. The simple moving average for the past 20 days is -27.48% for PBM’s stock, with a -91.26% simple moving average for the past 200 days.
PBM Trading at -47.70% from the 50-Day Moving Average
After a stumble in the market that brought PBM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.67% of loss for the given period.
Volatility was left at 16.52%, however, over the last 30 days, the volatility rate increased by 14.14%, as shares sank -52.58% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -70.58% lower at present.
During the last 5 trading sessions, PBM fell by -9.29%, which changed the moving average for the period of 200-days by -95.16% in comparison to the 20-day moving average, which settled at $0.0661. In addition, Psyence Biomedical Ltd saw -99.48% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for PBM
The total capital return value is set at 155.06. Equity return is now at value 1.27, with 1.13 for asset returns.
Based on Psyence Biomedical Ltd (PBM), the company’s capital structure generated -19.88 points at debt to capital in total, while cash flow to debt ratio is standing at -48.2.
Currently, EBITDA for the company is -2.75 million with net debt to EBITDA at -0.01. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.01.
Conclusion
In conclusion, Psyence Biomedical Ltd (PBM) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
